BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic product launches. Sales for the quarter rose by 23% to SEK 365 million ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Check a company’s competitiveness in the job market with alternative data that tracks hiring, job openings, and more.